{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:47Z","timestamp":1792800407743,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Persistent foetal vasculature (PFV) is a spectrum of congenital malformations arising from incomplete regression of the hyaloid\u2013tunica vasculosa lentis complex. Since Reese\u2019s original description of\n                    <jats:italic>persistent hyperplastic primary vitreous<\/jats:italic>\n                    and Goldberg\u2019s seminal reinterpretation of PFV as a unified developmental spectrum, our understanding has expanded through advances in genetics, imaging, and vitreoretinal surgery. PFV remains one of the most challenging causes of unilateral childhood visual loss. Although modern microsurgical techniques now deliver consistent anatomical success and globe preservation, functional vision is often limited by primary retinal and optic-nerve maldevelopment. This review traces the evolution of PFV management from its embryological basis to current surgical paradigms, integrating evidence from major series and highlighting practical lessons from contemporary vitreoretinal practice.\n                  <\/jats:p>","DOI":"10.1038\/s41433-026-04959-3","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:52:10Z","timestamp":1791309130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5250-6404","authenticated-orcid":false,"given":"Robert H.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"4959_CR1","first-page":"271","volume":"59","author":"AB Reese","year":"1955","unstructured":"Reese AB. Persistent hyperplastic primary vitreous. Trans Am Acad Ophthalmol Otolaryngol. 1955;59:271\u201395.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"4959_CR2","doi-asserted-by":"crossref","unstructured":"Goldberg MF. Persistent Fetal Vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 1997;124:587\u2013626 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9372715 Available at","DOI":"10.1016\/S0002-9394(14)70899-2"},{"key":"4959_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/eye.2016.159","volume":"30","author":"AL Solebo","year":"2016","unstructured":"Solebo AL, Russell-Eggitt I, Cumberland P, Rahi JS. Congenital cataract associated with persistent fetal vasculature: findings from IoLunder2. Eye. 2016;30:1204\u20139.","journal-title":"Eye"},{"key":"4959_CR4","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65079-1","volume":"156","author":"SJ Mandriota","year":"2000","unstructured":"Mandriota SJ, Pyke C, Sanza CD, Quinodoz P, Pittet B, Pepper MS. Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue Ischemia. Am J Pathol. 2000;156:2077\u201389.","journal-title":"Am J Pathol"},{"key":"4959_CR5","doi-asserted-by":"publisher","first-page":"12171","DOI":"10.1074\/jbc.M305146200","volume":"279","author":"P Pichiule","year":"2004","unstructured":"Pichiule P, Chavez JC, LaManna JC. Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial Cells*. J Biol Chem. 2004;279:12171\u201380.","journal-title":"J Biol Chem"},{"key":"4959_CR6","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI126655","volume":"129","author":"A Rattner","year":"2019","unstructured":"Rattner A, Williams J, Nathans J. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J Clin Investig. 2019;129:3807\u201320.","journal-title":"J Clin Investig"},{"key":"4959_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0092-8674(93)80047-I","volume":"74","author":"RA Lang","year":"1993","unstructured":"Lang RA, Bishop JM. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell. 1993;74:453\u201362.","journal-title":"Cell"},{"key":"4959_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature03928","volume":"437","author":"IB Lobov","year":"2005","unstructured":"Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature. 2005;437:417\u201321.","journal-title":"Nature"},{"key":"4959_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1084\/jem.20151966","volume":"213","author":"Y Yoshikawa","year":"2016","unstructured":"Yoshikawa Y, Yamada T, Tai-Nagara I, Okabe K, Kitagawa Y, Ema M, et al. Developmental regression of hyaloid vasculature is triggered by neurons. J Exp Med. 2016;213:1175\u201383.","journal-title":"J Exp Med"},{"key":"4959_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","volume":"139","author":"X Ye","year":"2009","unstructured":"Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, et al. Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization. Cell. 2009;139:285\u201398.","journal-title":"Cell"},{"key":"4959_CR11","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.ajpath.2016.06.015","volume":"186","author":"Z Wang","year":"2016","unstructured":"Wang Z, Liu C-H, Sun Y, Gong Y, Favazza TL, Morss PC, et al. Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy. Am J Pathol. 2016;186:2588\u20132600.","journal-title":"Am J Pathol"},{"key":"4959_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.molmed.2010.07.003","volume":"16","author":"X Ye","year":"2010","unstructured":"Ye X, Wang Y, Nathans J. The Norrin\/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med. 2010;16:417\u201325.","journal-title":"Trends Mol Med"},{"key":"4959_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2009.07.048","volume":"139","author":"HJ Junge","year":"2009","unstructured":"Junge HJ, Yang S, Burton JB, Paes K, Shu X, French DM, et al. TSPAN12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4\/\u03b2-Catenin Signaling. Cell. 2009;139:299\u2013311.\u00a0","journal-title":"Cell"},{"key":"4959_CR14","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1093\/hmg\/dds197","volume":"21","author":"L Prasov","year":"2012","unstructured":"Prasov L, Masud T, Khaliq S, Mehdi SQ, Abid A, Oliver ER, et al. ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary vitreous. Hum Mol Genet. 2012;21:3681\u201394.","journal-title":"Hum Mol Genet"},{"key":"4959_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nn.2798","volume":"14","author":"NM Ghiasvand","year":"2011","unstructured":"Ghiasvand NM, Rudolph DD, Mashayekhi M, Brzezinski JA, Goldman D, Glaser T. Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease. Nat Neurosci. 2011;14:578\u201386.","journal-title":"Nat Neurosci"},{"key":"4959_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/cells13131142","volume":"13","author":"D Atac","year":"2024","unstructured":"Atac D, Maggi K, Feil S, Maggi J, Cuevas E, Sowden JC, et al. Identification and Characterization of ATOH7-Regulated Target Genes and Pathways in Human Neuroretinal Development. Cells. 2024;13:1142.","journal-title":"Cells"},{"key":"4959_CR17","doi-asserted-by":"publisher","first-page":"690594","DOI":"10.3389\/fmed.2021.690594","volume":"8","author":"DM Thomas","year":"2021","unstructured":"Thomas DM, Kannabiran C, Balasubramanian D. Identification of Key Genes and Pathways in Persistent Hyperplastic Primary Vitreous of the Eye Using Bioinformatic Analysis. Front Med. 2021;8:690594.","journal-title":"Front Med"},{"key":"4959_CR18","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3390\/ijms24065836","volume":"24","author":"H-C Huang","year":"2023","unstructured":"Huang H-C, Lai C-H, Kang EY-C, Chen K-J, Wang N-K, Liu L, et al. Retrospective Analysis of Surgical Outcomes on Axial Length Elongation in Eyes with Posterior and Combined Persistent Fetal Vasculature. Int J Mol Sci. 2023;24:5836.","journal-title":"Int J Mol Sci"},{"key":"4959_CR19","first-page":"487","volume":"95","author":"ZF Pollard","year":"1997","unstructured":"Pollard ZF. Persistent hyperplastic primary vitreous: diagnosis, treatment and results. Trans Am Ophthalmol Soc. 1997;95:487\u2013549.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4959_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archopht.116.9.1190","volume":"116","author":"RA Mittra","year":"1998","unstructured":"Mittra RA, Huynh LT, Ruttum MS, Mieler WF, Connor TB, Han DP, et al. Visual Outcomes Following Lensectomy and Vitrectomy for Combined Anterior and Posterior Persistent Hyperplastic Primary Vitreous. Arch Ophthalmol. 1998;116:1190\u20134.","journal-title":"Arch Ophthalmol"},{"key":"4959_CR21","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ophtha.2010.03.062","volume":"117","author":"RA Sisk","year":"2010","unstructured":"Sisk RA, Berrocal AM, Feuer WJ, Murray TG. Visual and Anatomic Outcomes With or Without Surgery in Persistent Fetal Vasculature. Ophthalmology. 2010;117:2178\u20132183.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.062.","journal-title":"Ophthalmology"},{"key":"4959_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2023.03.027","volume":"130","author":"GS de Saint Sauveur","year":"2023","unstructured":"de Sauveur GS, Chapron T, Abdelmassih Y, Chehaibou I, Lecler A, Dureau P, et al. Management and Outcomes of Posterior Persistent Fetal Vasculature. Ophthalmology. 2023;130:844\u201353.","journal-title":"Ophthalmology"},{"key":"4959_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jcrs.2003.07.015","volume":"30","author":"A M\u00fcllner-Eidenb\u00f6ck","year":"2004","unstructured":"M\u00fcllner-Eidenb\u00f6ck A, Amon M, Hauff W, Klebermass N, Abela C, Moser E. Surgery in unilateral congenital cataract caused by persistent fetal vasculature or minimal fetal vascular remnants. J Cataract Refract Surg. 2004;30:611\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"4959_CR24","doi-asserted-by":"crossref","unstructured":"Group IATSInfant Aphakia Treatment Study: Effects of persistent fetal vasculature on outcome at 1 year of age. J AAPOS. 2011;15:427\u201331.","DOI":"10.1016\/j.jaapos.2011.06.004"},{"key":"4959_CR25","doi-asserted-by":"publisher","first-page":"e000656","DOI":"10.1136\/bmjophth-2020-000656","volume":"6","author":"N Khandwala","year":"2021","unstructured":"Khandwala N, Besirli C, Bohnsack BL. Outcomes and surgical management of persistent fetal vasculature. BMJ Open Ophthalmol. 2021;6:e000656.","journal-title":"BMJ Open Ophthalmol"},{"key":"4959_CR26","doi-asserted-by":"publisher","first-page":"327.e1","DOI":"10.1016\/j.jaapos.2019.07.009","volume":"23","author":"BM Bata","year":"2019","unstructured":"Bata BM, Chiu HH, Mireskandari K, Ali A, Lam W-C, Wan MJ. Long-term visual and anatomic outcomes following early surgery for persistent fetal vasculature: a single-center, 20-year review. J Am Assoc Pediatr Ophthalmol Strabismus. 2019;23:327.e1\u2013327.e5.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"4959_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2023.11.002","volume":"260","author":"KM Haider","year":"2024","unstructured":"Haider KM, Repka MX, Sutherland DR, Hatt SR, Fallaha N, Kraker RT, et al. Outcomes and Complications 5 Years After Surgery for Pediatric Cataract Associated With Persistent Fetal Vasculature. Am J Ophthalmol. 2024;260:30\u201336.","journal-title":"Am J Ophthalmol"},{"key":"4959_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/bjo.2004.053595","volume":"89","author":"A Hunt","year":"2005","unstructured":"Hunt A, Rowe N, Lam A, Martin F. Outcomes in persistent hyperplastic primary vitreous. Br J Ophthalmol. 2005;89:859-863.","journal-title":"Br J Ophthalmol"},{"key":"4959_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1523\/JNEUROSCI.4756-04.2005","volume":"25","author":"A Ohlmann","year":"2005","unstructured":"Ohlmann A, Scholz M, Goldwich A, Chauhan BK, Hudl K, Ohlmann AV, et al. Ectopic Norrin Induces Growth of Ocular Capillaries and Restores Normal Retinal Angiogenesis in Norrie Disease Mutant Mice. J Neurosci. 2005;25:1701\u201310.","journal-title":"J Neurosci"},{"key":"4959_CR30","doi-asserted-by":"publisher","first-page":"e13977","DOI":"10.15252\/emmm.202113977","volume":"13","author":"R Chidiac","year":"2021","unstructured":"Chidiac R, Abedin MD, Macleod G, Yang A, Thibeault PE, Blazer LL, et al. A Norrin\/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy. EMBO Mol Med. 2021;13:e13977.","journal-title":"EMBO Mol Med"},{"key":"4959_CR31","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/pharmaceutics14112476","volume":"14","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Lee S-J, Li Y. Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases. Pharmaceutics. 2022;14:2476.","journal-title":"Pharmaceutics"},{"key":"4959_CR32","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317393","volume":"15","author":"V Pauzuolyte","year":"2023","unstructured":"Pauzuolyte V, Patel A, Wawrzynski JR, Ingham NJ, Leong YC, Karda R, et al. Systemic gene therapy rescues retinal dysfunction and hearing loss in a model of Norrie disease. EMBO Mol Med. 2023;15:e17393.","journal-title":"EMBO Mol Med"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04959-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:02:28Z","timestamp":1791352948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04959-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":32,"alternative-id":["4959"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04959-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}